Zobrazeno 1 - 10
of 110
pro vyhledávání: '"C. Cachera"'
Publikováno v:
Journal of Lipid Research, Vol 29, Iss 1, Pp 77-84 (1988)
Apolipoprotein A-I (apoA-I), the major protein component of human high density lipoprotein, appears intracellularly as an intermediate precursor (proapoA-I) with a hexapeptide extension (Arg-His-Phe-Trp-Gln-Gln) at its amino terminus. To investigate
Externí odkaz:
https://doaj.org/article/064448766381487cbc3885c27e686494
Autor:
Jean-Charles Fruchart, Hafid Mezdour, Michel Dracon, C. Cachera, Véronique Reade, Majid Kandoussi, Richard Reade
Publikováno v:
American Journal of Nephrology. 16:394-401
Abnormalities in cholesteryl ester transfers may play a role in the development of atherosclerosis observed in patients with end-stage renal failure treated by chronic hemodialysis. Net neutral-lipid transfers and cholesteryl ester transfer protein a
Autor:
C. Cachera, Michel Dracon, Abdelmajid Kandoussi, Valérie Hugue, H J Parra, Jean Charles Fruchart, Albert Tacquet
Publikováno v:
American Journal of Nephrology. 16:287-292
Whole plasma from 6 normolipidemic chronic renal failure (CRF) patients undergoing hemodialysis treatment was passed through the anti-apolipoprotein (Apo) AI immunosorbent column connected to the anti-Apo B immunoaffinity column. Apo AI and B contain
Autor:
Pascal Harduin, Véronique Reade, C Cachera, Catherine Fievet, Jean-Charles Fruchart, Anne Tailleux, Albert Tacquet, Richard Reade
Publikováno v:
Kidney International. 44(6):1360-1365
Expression of apolipoprotein B epitopes in low density lipoproteins of hemodialyzed patients. Serum and isolated low-density lipoprotein (LDL) composition abnormalities were investigated in 20 hemodialyzed patients with chronic renal failure and 15 h
Publikováno v:
Journal de la Recherche Scientifique de l’Université de Lomé; Vol 7, No 2 (2005): Serie A
No Abtract.
Autor:
Philippe Amouyel, Patrick Duriez, C Cachera, Albert Tacquet, Jean-Charles Fruchart, Francoise Monard, Jean-Marie Bard, Dominique Gairin
Publikováno v:
Clinica Chimica Acta. 193:165-179
Lipoprotein particles containing apolipoproteins (Apo) were studied by enzyme-linked-immunosorbent assay in two homozygous familial hypercholesterolemic patients (1 male and 1 female) with portacaval shunts, and in controls. Total Apo B, total choles
Autor:
M. Dracon, Abdelmejid Kandoussi, C. Cachera, V. Hugue, Christian Noel, M. Hazzan, Albert Tacquet
Publikováno v:
Nephron. 80(2)
Plasma lipoprotein (a) (LP(a)) concentrations are increased in patients with end-stage renal disease. Considering the influence of the apolipoprotein (a) (Apo(a)) polymorphism and the mode of dialysis in this prospective longitudinal study, we compar
Publikováno v:
Late Graft Loss ISBN: 9789401062862
The cardiovascular complications remain an important cause of morbidity and mortality in dialysis patients and in the long term outcome of the kidney transplant recipients. Lipoprotein(a) [Lp(a)]: which concentrations are often raised in dialysis pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28bbd9c56e9d330e6e8dfdbc95868749
https://doi.org/10.1007/978-94-011-5434-5_51
https://doi.org/10.1007/978-94-011-5434-5_51
Publikováno v:
Nephrology Dialysis Transplantation.
Plasma lipids and apolipoproteins were determined in 18 patients with chronic renal failure on haemodialysis (HD), 18 patients on continuous ambulatory peritoneal dialysis (CAPD), and 18 healthy controls. Significant differences were observed between
Publikováno v:
Annales de biologie clinique. 48(6)
Antibodies directed against designed apolipoprotein, were absorbed on microtiter plates, the other apolipoprotein present on the retained particles was evaluated by using corresponding peroxidase labeled antibodies. This differential antibody immunos